Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $105.5800 (-0.86%) ($104.1800 - $107.1900) on Wed. Jan. 6, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.75% (three month average) | RSI | 62 | Latest Price | $105.5800(-0.86%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.2% a day on average for past five trading days. | Weekly Trend | ABBV advances 1% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(46%) SPLV(36%) VYM(33%) XLP(33%) DIA(32%) | Factors Impacting ABBV price | ABBV will decline at least -0.875% in a week (0% probabilities). VIXM(-23%) UUP(-10%) VXX(-5%) IGOV(-2%) TLT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.875% (StdDev 1.75%) | Hourly BBV | 0.5 () | Intraday Trend | 0.8% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $105.98(-0.38%) | 10 Day Moving Average | $104.82(0.73%) | 20 Day Moving Average | $105.09(0.47%) | To recent high | -2.8% | To recent low | 31.2% | Market Cap | $186.273b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |